CellSolutions

CellSolutions is a medical device and diagnostics company specializing in liquid-based cytology (LBC) and molecular diagnostics. The company provides automated and manual processing systems designed to improve the accuracy and efficiency of cancer screening, particularly for cervical cancer. Its core technologies include the BestPrep and CellSolutions 30 systems, which utilize proprietary reagents like GluCyte for cell preservation and slide preparation. Following its acquisition by EKF Diagnostics in 2022, CellSolutions continues to offer a range of laboratory solutions for pathology and clinical diagnostics globally. The company's products are used by laboratories to streamline workflow and enhance diagnostic clarity in cytopathology.